Budget Impact Analysis of EGFR Mutation Liquid Biopsy for First- and Second-Line Treatment of Metastatic Non-Small Cell Lung Cancer in Greece

por Cheng, Mindy, Akalestos, Athanasios, Scudder, Sidney
Publicado 2020

The Clinical and Economic Impact of Inaccurate EGFR Mutation Tests in the Treatment of Metastatic Non-Small Cell Lung Cancer

por Cheng, Mindy M., Palma, John F., Scudder, Sidney, Poulios, Nick, Liesenfeld, Oliver
Publicado 2017

Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer

por Ho, Hsiang-Ling, Jiang, Yuqiu, Chiang, Chi-Lu, Karwowska, Sylwia, Yerram, Ranga, Sharma, Keerti, Scudder, Sidney, Chiu, Chao-Hua, Tsai, Chun-Ming, Palma, John F., Sharma, Abha, Chou, Teh-Ying
Publicado 2022